As support for marijuana legalization in America reaches an all-time high, NORML chapters around the country are hoping to tap into the energy and enthusiasm of their most ardent supporters for their 2018 lobby days.
Year: 2017
In the wake of landmark cannabis victories in 2016, there was much momentum to build upon when state legislatures opened up at the beginning of 2017. With NORML chapters in nearly all 50 states, activists took the fight to the halls of state capitals and city councils from Florida to Washington State and everywhere in between. In all, lawmakers in 26 states have passed legislation to advance cannabis reform.
Select retailers will begin engaging in adult use marijuana sales on the morning of Monday, January 1. California joins Alaska, Colorado, Nevada, Oregon, and Washington in permitting cannabis sales to those over the age of 21.
From all of us at NORML to all of you, we hope you have a very, very green Christmas.
Congressional leadership voted to enact a four-week continuing resolution that maintains present federal spending levels and priorities through January 19, 2018. The resolution extends medical cannabis patient protections imposed by the Rohrabacher-Blumenauer amendment until that date.
In June of 2016 members of Peachtree NORML began a practice of visiting official law enforcement Facebook pages when marijuana bust “brag” posts were put up. We began expressing our opinions on those posts. Those opinions were often deleted from these official pages and the citizens making them were blocked from commenting. These actions are an abridgment of a citizen’s First Amendment Right to criticize a governmental official or entity. Sheriff Joey Terrell of Habersham County, Georgia was one of the officials who deleted dissenting comments. We decided to contact the ACLU, and they decided to take up our case for us.
During a House Democrats meeting on Wednesday morning, the caucus elected marijuana reform supporter Representative Jerry Nadler (D-NY) to be the party leader on the powerful Judiciary Committee.
The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data published online ahead of print in The American Journal of Psychiatry.